Search research articles
Contact Us
Filters
Showing results (21-30 of 251) with videos related to
Page
of 26
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 4, 2006
Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice
Rana Samadfam, Qingwen Xia, David Goltzman
Endocrinology
|
March 24, 2007
Pretreatment with anticatabolic agents blunts but does not eliminate the skeletal anabolic response to parathyroid hormone in oophorectomized mice
Rana Samadfam, Qingwen Xia, David Goltzman
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 16, 2004
Vitamin D analogs as therapeutic agents: a clinical study update
J Ruth Wu-Wong, Jin Tian, David Goltzman
American Journal of Physiology. Endocrinology and Metabolism
|
October 25, 2012
Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor
Dibyendu Kumar Panda, David Goltzman, Andrew C Karaplis
Endocrinology
|
July 7, 2007
Early lethality in Hyp mice with targeted deletion of Pth gene
Xiuying Bai, Dengshun Miao, David Goltzman, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|
October 7, 2020
Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis?
Brian Lentle, Jacques P Brown, Linda Probyn, et al.
The Journal of Clinical Investigation
|
May 8, 2002
Parathyroid hormone is essential for normal fetal bone formation
Dengshun Miao, Bin He, Andrew C Karaplis, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 27, 2009
TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation
Dibiyendu Panda, David Goltzman, Harald Jüppner, et al.
The Journal of Biological Chemistry
|
January 10, 2003
The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
Xiu-Ying Bai, Dengshun Miao, David Goltzman, et al.
The American Journal of Pathology
|
September 25, 2024
Retraction notice to "Bone Marrow Ablation Demonstrates That Excess Endogenous Parathyroid Hormone Plays Distinct Roles in Trabecular and Cortical Bone" [Am J Pathol 181 (2012) 234-244]
Jun Yan, Weiwei Sun, Jing Zhang, et al.
Page
of 26
Search research articles
Search
Showing results (21-30 of 251) with videos related to
Sort By:
Page
of 26
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 4, 2006
Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice
Rana Samadfam, Qingwen Xia, David Goltzman
Endocrinology
|
March 24, 2007
Pretreatment with anticatabolic agents blunts but does not eliminate the skeletal anabolic response to parathyroid hormone in oophorectomized mice
Rana Samadfam, Qingwen Xia, David Goltzman
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 16, 2004
Vitamin D analogs as therapeutic agents: a clinical study update
J Ruth Wu-Wong, Jin Tian, David Goltzman
American Journal of Physiology. Endocrinology and Metabolism
|
October 25, 2012
Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor
Dibyendu Kumar Panda, David Goltzman, Andrew C Karaplis
Endocrinology
|
July 7, 2007
Early lethality in Hyp mice with targeted deletion of Pth gene
Xiuying Bai, Dengshun Miao, David Goltzman, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|
October 7, 2020
Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis?
Brian Lentle, Jacques P Brown, Linda Probyn, et al.
The Journal of Clinical Investigation
|
May 8, 2002
Parathyroid hormone is essential for normal fetal bone formation
Dengshun Miao, Bin He, Andrew C Karaplis, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
August 27, 2009
TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation
Dibiyendu Panda, David Goltzman, Harald Jüppner, et al.
The Journal of Biological Chemistry
|
January 10, 2003
The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency
Xiu-Ying Bai, Dengshun Miao, David Goltzman, et al.
The American Journal of Pathology
|
September 25, 2024
Retraction notice to "Bone Marrow Ablation Demonstrates That Excess Endogenous Parathyroid Hormone Plays Distinct Roles in Trabecular and Cortical Bone" [Am J Pathol 181 (2012) 234-244]
Jun Yan, Weiwei Sun, Jing Zhang, et al.
Page
of 26